🔎 Trials Near Me

Akèy › Skleroz Miltip › Alabama › Birmingham

Etid klinik pou Skleroz Miltip nan Birmingham, AL

8 etid pou Skleroz Miltip ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Ap rekriteFaz 2
  • Alabama Neurology Associates, Birmingham
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT06782490

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07475377

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Ap rekriteEtid obsèvasyon
  • TG Therapeutics Investigational Trial Site, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Ap rekriteFaz 3
  • Alabama Neurology Associates- Site Number : 8400115, Homewood · 3 mi lwen
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Ap rekriteFaz 2
  • UAB, Psychiatry and Behavioral Neurology, Birmingham
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Ap rekriteFaz 3
  • Alabama Neurology Associates PC, Birmingham
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Ap rekriteFaz 1Volontè an sante akeyi
  • University of Alabama at Birmingham Medical Center, Birmingham
Laj 18 a 65 · Tout sèks · Mizajou Jun 2, 2026 · NCT03759522

Care in Multiple Sclerosis (MS)

Ap rekriteEtid obsèvasyon
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT07011914

Etid Skleroz Miltip nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.